Karaca, M. Et Al. 2017. Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors. 42nd European-Society-for-Medical-Oncology Congress (ESMO) , (Madrid, Spain).

Karaca, M., Tural, D., Cil, I., Ozet, G., Yucel, O. K., & Ozet, A., (2017). Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors . 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain

Karaca, M. Et Al. "Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors," 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 2017

Karaca, M. Et Al. "Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain, 2017

Karaca, M. Et Al. (2017) . "Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors." 42nd European-Society-for-Medical-Oncology Congress (ESMO) , Madrid, Spain.

@conferencepaper{conferencepaper, author={M. Karaca Et Al. }, title={Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumors}, congress name={42nd European-Society-for-Medical-Oncology Congress (ESMO)}, city={Madrid}, country={Spain}, year={2017}}